Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-10945.93%EBITDA Margin
VS
Market
Sector
Industry
History
$ 37.25Close
$ 10.84 - $ 37.25 52-Week Range
Ticker Information
Ticker
INBXCompany Name
INHIBRX BIOSCIENCES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQINHIBRX BIOSCIENCES INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
INBX - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -153.24M | -10945.93% | $ 1.4M |
| 3/31/2025 | $ 1.74B | 867744.5% | $ 200K |
| 12/31/2024 | $ 1.71B | 852623.5% | $ 200K |
| 12/31/2023 | $ -206.56M | -11475.67% | $ 1.8M |
Key Performance Insights, Last 5 Years
- INHIBRX BIOSCIENCES INC's latest trailing twelve months (TTM) EBITDA % stands at -11475.67%.
- Over the past 5 years, INHIBRX BIOSCIENCES INC's average EBITDA % has been 424486.6%.
- The median EBITDA % for INHIBRX BIOSCIENCES INC during this period was 420838.79%
- INHIBRX BIOSCIENCES INC reached its highest EBITDA % over the past 5 years at 867744.5%.
- The lowest EBITDA % recorded by INHIBRX BIOSCIENCES INC in the same timeframe -11475.67%
INHIBRX BIOSCIENCES INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for INHIBRX BIOSCIENCES INC is calculated as follows: EBITDA [ $ -206.56M ] / Revenues [ $ 1.8M ]
(=) EBITDA % [ -11475.67% ] INBX - EBITDA Margin, Last 5 years
-11475.67%
Minimum
Dec 31, 2023
867744.5%
Maximum
Mar 31, 2025
424486.6%
Average
420838.79%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |